Poltra Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.21 M
as on 04-12-2024
- Revenue 17.71%
(FY 2022)
- Profit -128.13%
(FY 2022)
- Ebitda -83.03%
(FY 2022)
- Net Worth -21.97%
(FY 2022)
- Total Assets -4.41%
(FY 2022)
About Poltra Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.21 M.
Raghvendra Singh, Ambrish Trivedi, and Amit Jaiswal serve as directors at the Company.
- CIN/LLPIN
U15136UP2020PTC136202
- Company No.
136202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Poltra Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghvendra Singh  | Director | 14-Oct-2020 | Current |
| Ambrish Trivedi | Director | 14-Oct-2020 | Current |
| Amit Jaiswal | Director | 14-Oct-2020 | Current |
Financial Performance of Poltra Biotech.
Poltra Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.71% increase. The company also saw a substantial fall in profitability, with a 128.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Poltra Biotech?
Unlock access to Poltra Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sunvet Health Private LimitedActive 2 years 3 monthsAmbrish Trivedi and Amit Jaiswal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Aug 2021 | ₹0.21 M | Open |
How Many Employees Work at Poltra Biotech?
Poltra Biotech has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Poltra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Poltra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
